Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$0.83 - $1.12 $24,980 - $33,708
-30,097 Reduced 87.36%
4,356 $3,000
Q1 2023

May 09, 2023

SELL
$0.91 - $1.69 $936 - $1,739
-1,029 Reduced 2.9%
34,453 $35,000
Q4 2022

Feb 08, 2023

SELL
$1.09 - $2.04 $693 - $1,297
-636 Reduced 1.76%
35,482 $44,000
Q3 2022

Nov 04, 2022

SELL
$1.55 - $3.01 $10,378 - $20,154
-6,696 Reduced 15.64%
36,118 $57,000
Q2 2022

Jul 29, 2022

SELL
$1.39 - $3.12 $7,626 - $17,119
-5,487 Reduced 11.36%
42,814 $83,000
Q1 2022

May 05, 2022

SELL
$2.6 - $4.17 $108,396 - $173,851
-41,691 Reduced 46.33%
48,301 $145,000
Q4 2021

Jan 21, 2022

SELL
$3.64 - $7.78 $112,330 - $240,090
-30,860 Reduced 25.54%
89,992 $326,000
Q3 2021

Nov 08, 2021

BUY
$6.01 - $8.71 $11,328 - $16,418
1,885 Added 1.58%
120,852 $949,000
Q2 2021

Aug 04, 2021

BUY
$6.02 - $9.64 $343,615 - $550,241
57,079 Added 92.23%
118,967 $863,000
Q1 2021

May 10, 2021

SELL
$9.17 - $14.8 $341,930 - $551,862
-37,288 Reduced 37.6%
61,888 $580,000
Q4 2020

Feb 08, 2021

BUY
$8.92 - $13.29 $186,231 - $277,468
20,878 Added 26.66%
99,176 $1.12 Million
Q3 2020

Nov 09, 2020

BUY
$9.94 - $16.59 $319,739 - $533,650
32,167 Added 69.73%
78,298 $837,000
Q2 2020

Aug 05, 2020

BUY
$12.07 - $19.34 $134,001 - $214,712
11,102 Added 31.69%
46,131 $699,000
Q1 2020

May 06, 2020

SELL
$12.5 - $22.04 $304,162 - $536,299
-24,333 Reduced 40.99%
35,029 $544,000
Q3 2019

Nov 01, 2019

BUY
$14.74 - $22.28 $874,995 - $1.32 Million
59,362 New
59,362 $1.08 Million

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.